Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Pediatric systemic lupus erythematosus is a severe autoimmune disease in children requiring early diagnosis and comprehensive management.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Woman has discoid lupus, frontal fibrosing, and androgenetic alopecia.

Early scar classification in lupus can improve treatment and patient outcomes.

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

The CLASI is useful but needs revision to accurately assess all cutaneous lupus erythematosus subtypes.

A 5-year-old girl's scalp scarring and hair loss from lupus improved with specific medications.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

A woman with lupus and severe nerve damage improved with specific treatments.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

The patient's scalp lesions stabilized with a combination of treatments after initial therapies failed.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

The A allele of the C2 gene increases the risk of lupus, while the G allele may protect against it.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

Early and aggressive treatment can significantly regrow hair in discoid lupus erythematosus.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Teenage girls with Lupus often struggle with the disease's impact on their looks, which may lead them to change their medication without a doctor's advice.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.